Skip to content
healthcare.dev
Get a free key

Medroxyprogesterone Acetate

NDC 0555-0779, Medroxyprogesterone Acetate, tablet, from Teva Pharmaceuticals USA, Inc..

Product NDC
0555-0779
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040159
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0555-0779 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEDROXYPROGESTERONE ACETATE10 mg/1

Pharmacologic classes

Progesterone Congeners [CS]; Progestin [EPC]

Package NDCNDC-11Package
0555-0779-0200555077902100 TABLET in 1 BOTTLE (0555-0779-02)
0555-0779-0400555077904500 TABLET in 1 BOTTLE (0555-0779-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9eb200b0-db96-4a51-87ea-04db862978c8

  • NADAC price for package 00555077902

    GET /v1/drugs/nadac/00555077902

  • NADAC price for package 00555077904

    GET /v1/drugs/nadac/00555077904

Use it

Look up 0555-0779 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0555-0779 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0555-0779. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.